I-Mab (IMAB) Stock Chart & Stock Price History $0.85 +0.01 (+1.03%) Closing price 04/17/2025 03:58 PM EasternExtended Trading$0.85 0.00 (-0.35%) As of 04/17/2025 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock I-Mab Stock Price Performance 5 Day Performance+27.63%1 Month Performance0.00%3 Month Performance-20.56%6 Month Performance-42.57%Year-To-Date Performance0.00%1 Year Performance-52.78% Receive IMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. Email Address IMAB Stock Chart for Friday, April, 18, 2025 IMAB Chart by TradingView I-Mab Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/17/2025$0.84$0.85+1.03%$0.85$0.8333,911 shs$69.28 million04/16/2025$0.91$0.84-7.26%$0.93$0.83137,816 shs$68.57 million04/15/2025$0.96$0.91-5.07%$0.94$0.85212,816 shs$73.94 million04/14/2025$0.67$0.96+43.50%$1.01$0.691.39 million shs$77.89 million04/11/2025$0.67$0.67-1.22%$0.67$0.6370,517 shs$54.28 million04/10/2025$0.69$0.67-2.12%$0.72$0.6549,123 shs$54.95 million04/09/2025$0.69$0.69+0.41%$0.72$0.62163,039 shs$56.14 million04/09/2025$0.69$0.69+0.41%$0.72$0.62163,039 shs$56.14 million04/08/2025$0.62$0.69+10.65%$0.78$0.64602,948 shs$55.91 million04/08/2025$0.62$0.69+10.65%$0.78$0.64602,948 shs$55.91 million Get the Latest News and Ratings for IMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. 04/07/2025$0.68$0.62-8.82%$0.79$0.61747,891 shs$50.53 million04/04/2025$0.73$0.68-6.86%$0.70$0.60386,421 shs$55.42 million04/03/2025$0.78$0.73-6.19%$0.75$0.70229,519 shs$59.50 million04/02/2025$0.79$0.78-1.21%$0.82$0.76131,755 shs$63.43 million04/01/2025$0.82$0.79-4.38%$0.83$0.77104,487 shs$64.21 million03/31/2025$0.84$0.82-2.07%$0.83$0.78142,459 shs$67.15 million03/28/2025$0.84$0.84$0.86$0.81157,775 shs$68.57 million03/27/2025$0.84$0.84+0.63%$0.86$0.8261,390 shs$68.57 million03/26/2025$0.87$0.84-3.94%$0.87$0.83106,467 shs$68.14 million03/25/2025$0.87$0.87+0.29%$0.88$0.8670,746 shs$70.93 million03/24/2025$0.85$0.87+2.02%$0.87$0.84141,317 shs$70.73 million03/21/2025$0.86$0.85-1.20%$0.87$0.8579,570 shs$69.33 million03/20/2025$0.89$0.86-3.16%$0.90$0.83128,875 shs$70.16 million03/19/2025$0.85$0.89+4.59%$0.89$0.82159,937 shs$72.45 million03/18/2025$0.85$0.85$0.87$0.80446,813 shs$69.28 million03/17/2025$0.84$0.85+1.19%$0.86$0.84434,311 shs$69.28 million Related Companies Benitec Biopharma Stock Price Chart Allogene Therapeutics Stock Price Chart Oruka Therapeutics Stock Price Chart Alpha Teknova Stock Price Chart Entrada Therapeutics Stock Price Chart Mereo BioPharma Group Stock Price Chart Heron Therapeutics Stock Price Chart Cryoport Stock Price Chart COMPASS Pathways Stock Price Chart Olema Pharmaceuticals Stock Price Chart Receive IMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMAB) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding I-Mab Please log in to your account or sign up in order to add this asset to your watchlist. Share I-Mab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
